Lidocaine
Lidocaine Hydrochloride Injection USP
Approved
Approval ID
f1b26274-a55e-4321-b96c-ce0df830f205
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Aug 5, 2022
Manufacturers
FDA
Fresenius Kabi USA, LLC
DUNS: 608775388
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
LIDOCAINE HYDROCHLORIDE
PRODUCT DETAILS
NDC Product Code63323-208
Application NumberNDA017584
Marketing CategoryC73594
Route of AdministrationINTRAVENOUS
Effective DateAugust 5, 2022
Generic NameLIDOCAINE HYDROCHLORIDE
INGREDIENTS (4)
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
LIDOCAINE HYDROCHLORIDEActive
Quantity: 20 mg in 1 mL
Code: V13007Z41A
Classification: ACTIR
SODIUM CHLORIDEInactive
Quantity: 6 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT